Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
100%
Zebra Fish
100%
Heart Failure with Reduced Ejection Fraction
50%
End Stage Renal Disease
50%
Valsartan/Sacubitril
50%
Cardiovascular Toxicity
50%
Copper Nanoparticle
50%
Sjoegren Syndrome
50%
Verapamil
50%
Oxygenase
50%
Phosphatidylinositol 3 Kinase
50%
Heme
50%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
50%
Treatment Group
37%
Edema
31%
All Cause Mortality
29%
Heart Infarction
25%
Ecotoxicity
25%
Reactive Oxygen Metabolite
25%
Ischemia
25%
Non ST Segment Elevation Myocardial Infarction
18%
Mortality Rate
16%
Cohort Study
16%
Hospital Mortality
16%
Dipeptidyl Carboxypeptidase Inhibitor
12%
Beta Adrenergic Receptor Blocking Agent
12%
ST Segment Elevation Myocardial Infarction
12%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
12%
Angiotensin Receptor Antagonist
12%
Messenger RNA
12%
Critical Limb Ischemia
12%
Diabetes Mellitus
12%
Streptozotocin
12%
SLCO1B1
12%
Candesartan
8%
Valsartan
8%
Heart Failure
8%
Congestive Heart Failure
6%
Calcium
6%
Syndrome
6%
Long Term Exposure
6%
Fluorescein Isothiocyanate Dextran
6%
Observational Study
5%
Heart Arrhythmia
5%
Cardiogenic Shock
5%
Respiratory Failure
5%
Nursing and Health Professions
Acute Heart Infarction
100%
Propensity Score
50%
Sjoegren Syndrome
50%
Health Outcomes
50%
Treatment Group
37%
Heart Infarction
25%
All Cause Mortality
25%
Non ST Segment Elevation Myocardial Infarction
18%
Hospital Mortality
16%
ST Segment Elevation Myocardial Infarction
12%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
12%
Mortality Rate
12%
National Health Insurance
12%
Secondary Prevention
12%
Dipeptidyl Carboxypeptidase Inhibitor
12%
Practice Guideline
12%
Cohort Analysis
12%
Hazard Ratio
12%
Medication Compliance
12%
Beta Adrenergic Receptor Blocking Agent
12%
Health Care Quality
12%
Angiotensin Receptor Antagonist
12%
Cardiogenic Shock
5%
Logistic Regression Analysis
5%
Heart Arrhythmia
5%
Respiratory Failure
5%
Medicine and Dentistry
Acute Heart Infarction
50%
Sjoegren Syndrome
50%
Adverse Event
50%
Pharmacogenetics
50%
Anatomy Education
50%
Drug Response
25%
Personalized Medicine
25%
CYP2C9
25%
Hospital Mortality
16%
Circulating Endothelial Cell
12%
Azathioprine
12%
Statin
12%
Nonsteroid Antiinflammatory Agent
12%
Genetic Variability
12%
Breast Cancer Resistance Protein
12%
Retrospective Study
12%
Clopidogrel
12%
CYP2C19
12%
Propensity Score Matching
11%
Acute Renal Failure
5%
Observational Study
5%
Respiratory Failure
5%
Cardiogenic Shock
5%
Logistic Regression Analysis
5%
Cardiac Dysrhythmia
5%
Non ST Segment Elevation Myocardial Infarction
5%
